![David M. Fineman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David M. Fineman
Amministratore Delegato presso
KINEMED INC
Profilo
David M.
Fineman is the founder of KineMed, Inc. (founded in 2001) where he currently serves as the Chairman & Chief Executive Officer.
He was also the founder of Quark Pharmaceuticals, Inc. (founded in 1993) where he served as a Director.
Dr. Fineman's former job includes being the Acting Chief Financial Officer at SuperGen, Inc. (1990-2013).
Dr. Fineman's education history includes an undergraduate degree from the University of Maryland (conferred in 1966) and a graduate degree from The New School for Social Research.
Posizioni attive di David M. Fineman
| Società | Posizione | Inizio |
|---|---|---|
| KINEMED INC | Amministratore Delegato | 29/08/2013 |
Precedenti posizioni note di David M. Fineman
| Società | Posizione | Fine |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Fondatore | - |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Direttore Finanziario/CFO | - |
Formazione di David M. Fineman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
60
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The New School for Social Research
 The New School for Social Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
